| ID | Peptide Seq | Site Residue | Position in Peptide | Position in Protein |
|---|---|---|---|---|
| 10014895 | LRQSGEELPPTS | S | 12 | 227 |
| 10033181 | QSGEELPPTS | T | 9 | 226 |
| 10037110 | QSGEELPPTS | 227 | ||
| 10037237 | QSGEELPPTS | 227 | ||
| 10037485 | LRQSGEELPPTS | 227 |
| ID | Method | Analytical Throughput | Ambiguity | Species | Sample Type | Condition | log2Ratio | P Value | Data Source PMID | Comments |
|---|---|---|---|---|---|---|---|---|---|---|
| 10014895 | MS | HTP | unambiguous | human | HeLa cells | None | 31373491 | |||
| 10033181 | MS | HTP | unambiguous | human | Jurkat cells | None | 35705054 | |||
| 10037110 | MS | HTP | unambiguous | human | HepG2 cells | None | 30620550 | |||
| 10037237 | MS | HTP | unambiguous | human | HEK 293T cells | TMG/control | None | 30620550 | Peptide quantification value was applied to each modification site | |
| 10037485 | MS | HTP | unambiguous | human | HepG2 cells | orafenib sensitive/resistant | None | 30620550 | Peptide quantification value was applied to each modification site |
| ID | Peptide Seq | Site Residue | Position in Peptide | Position in Protein | Method | Analytical Throughput | Ambiguity | Species | Sample Type | Data Source PMID | Comments |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10014895 | LRQSGEELPPTS | S | 12 | 227 | MS | HTP | unambiguous | human | HeLa cells | 31373491 | |
| 10033181 | QSGEELPPTS | T | 9 | 226 | MS | HTP | unambiguous | human | Jurkat cells | 35705054 | |
| 10037110 | QSGEELPPTS | 227 | MS | HTP | unambiguous | human | HepG2 cells | 30620550 | |||
| 10037237 | QSGEELPPTS | 227 | MS | HTP | unambiguous | human | HEK 293T cells | 30620550 | Peptide quantification value was applied to each modification site | ||
| 10037485 | LRQSGEELPPTS | 227 | MS | HTP | unambiguous | human | HepG2 cells | 30620550 | Peptide quantification value was applied to each modification site |